Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Oncology Research
|
May 1, 2026
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study
Laura Duzzi, Nora Möhn, Emily Narten, et al.
Cancer Medicine
|
January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study
Jonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 17, 2020
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Critical Care Medicine
|
October 4, 2021
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults
Melissa R Hines, Tatiana von Bahr Greenwood, Gernot Beutel, et al.
Leukemia
|
April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2021
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Leukemia
|
January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents
Rabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Leukemia
|
February 25, 2025
Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN)
Kirsi Manz, Florian H Heidel, Steffen Koschmieder, et al.
Frontiers in Immunology
|
November 2, 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
Anna Christina Dragon, Luca Marie Beermann, Melina Umland, et al.
Journal of Cancer Research and Clinical Oncology
|
March 15, 2023
An overview and a roadmap for artificial intelligence in hematology and oncology
Wiebke Rösler, Michael Altenbuchinger, Bettina Baeßler, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Oncology Research
|
May 1, 2026
Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study
Laura Duzzi, Nora Möhn, Emily Narten, et al.
Cancer Medicine
|
January 26, 2025
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study
Jonas Paul Wiegmann, Tabea Fröhlich, Nora Möhn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 17, 2020
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Critical Care Medicine
|
October 4, 2021
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults
Melissa R Hines, Tatiana von Bahr Greenwood, Gernot Beutel, et al.
Leukemia
|
April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2021
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
Nicola Giesen, Rosanne Sprute, Maria Rüthrich, et al.
Leukemia
|
January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents
Rabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Leukemia
|
February 25, 2025
Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN)
Kirsi Manz, Florian H Heidel, Steffen Koschmieder, et al.
Frontiers in Immunology
|
November 2, 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
Anna Christina Dragon, Luca Marie Beermann, Melina Umland, et al.
Journal of Cancer Research and Clinical Oncology
|
March 15, 2023
An overview and a roadmap for artificial intelligence in hematology and oncology
Wiebke Rösler, Michael Altenbuchinger, Bettina Baeßler, et al.
Page
of 9